• News
  • SAN DIEGO
  • BioTech

Isis could gain $2 billion advantage from heart attack study

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Isis Pharmaceuticals Inc.

Company Website

1896 Rutherford Road
Carlsbad, CA 92008

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ISIS
55.36
  -0.07  
- 0.13%
2,259,920,000
77.8
27.37

Insider Trade Data

Date Insider Shares Type Value
07/02/2015 Monia, Brett P 198 Sell $11,147
07/01/2015 Crooke, Stanley T 6,175 Sell $355,439
07/01/2015 Crooke, Stanley T 6,175 Exchange $67,184
07/01/2015 Parshall, B Lynne 6,218 Sell $357,914
07/01/2015 Parshall, B Lynne 6,218 Exchange $63,983

Isis Pharmaceuticals Inc. Executive(s):

Stanley Crooke

  • Chief Executive Officer, Founder, President, Chairman

Similar Companies

NAICS - 325414 - Biological Product (except Diagnostic) Manufacturing
Subscribe Today!